Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Cannabinoids in the management of difficult to treat pain

Authors Ethan B Russo

Published 8 February 2008 Volume 2008:4(1) Pages 245—259


Ethan B Russo

GW Pharmaceuticals, Vashon, WA, USA

Abstract: This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment. Tetrahydrocannabinol (THC, Marinol®) and nabilone (Cesamet®) are currently approved in the United States and other countries, but not for pain indications. Other synthetic cannabinoids, such as ajulemic acid, are in development. Crude herbal cannabis remains illegal in most jurisdictions but is also under investigation. Sativex®, a cannabis derived oromucosal spray containing equal proportions of THC (partial CB1 receptor agonist) and cannabidiol (CBD, a non-euphoriant, anti-inflammatory analgesic with CB1 receptor antagonist and endocannabinoid modulating effects) was approved in Canada in 2005 for treatment of central neuropathic pain in multiple sclerosis, and in 2007 for intractable cancer pain. Numerous randomized clinical trials have demonstrated safety and efficacy for Sativex in central and peripheral neuropathic pain, rheumatoid arthritis and cancer pain. An Investigational New Drug application to conduct advanced clinical trials for cancer pain was approved by the US FDA in January 2006. Cannabinoid analgesics have generally been well tolerated in clinical trials with acceptable adverse event profiles. Their adjunctive addition to the pharmacological armamentarium for treatment of pain shows great promise.

Keywords: cannabinoids, tetrahydrocannabinol, cannabidiol, analgesia, pain management, multiple sclerosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Prevalence and factors predictive of intraocular fungal infection in patients with fungemia at an academic urban tertiary care center

Geraymovych E, Conduff JH, Braich PS, Leffler CT, Brar VS

Clinical Ophthalmology 2015, 9:1853-1858

Published Date: 29 September 2015

The genetics of premature ovarian failure: current perspectives

Chapman C, Cree L, Shelling AN

International Journal of Women's Health 2015, 7:799-810

Published Date: 23 September 2015

The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives

Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC

Clinical Interventions in Aging 2015, 10:1421-1429

Published Date: 3 September 2015

Scleral buckle hemorrhagic cyst masquerading as an orbital tumor

Almeida DRP, Chin EK, Boldt HC, Mahajan VB

Clinical Ophthalmology 2015, 9:343-345

Published Date: 13 February 2015

Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria

Okoye AE, Ibegbulam OG, Onoh RC, Ezeonu PO, Ugwu NI, Lawani LO, Anigbo CS, Nonyelu CE

International Journal of Women's Health 2014, 6:849-855

Published Date: 18 September 2014

Aflibercept in wet AMD: specific role and optimal use

Semeraro F, Morescalchi F, Duse S, Parmeggiani F, Gambicorti E, Costagliola C

Drug Design, Development and Therapy 2013, 7:711-722

Published Date: 5 August 2013

Is a bowel resection necessary for deep endometriosis with rectovaginal or colorectal involvement?

Acién P, Núñez C, Quereda F, Velasco I, Valiente M, Vidal V

International Journal of Women's Health 2013, 5:449-455

Published Date: 29 July 2013

Completeness of TNM cancer staging for melanoma in the Danish Cancer Registry, 2004–2009

Frøslev T, Grann AF, Olsen M, Olesen AB, Schmidt H, Friss S, Søgaard M

Clinical Epidemiology 2012, 4:5-10

Published Date: 17 August 2012

Selenium–vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate

Mohammad K Moslemi, Samaneh Tavanbakhsh

International Journal of General Medicine 2011, 4:99-104

Published Date: 23 January 2011

Nanofunctionalized zirconia and barium sulfate particles as bone cement additives

Riaz Gillani, Batur Ercan, Alex Qiao, et al

International Journal of Nanomedicine 2010, 5:1-11

Published Date: 17 December 2009